The Adult Therapeutics Handbook content has now been updated and includes the following main changes: Resuscitation and anaphylaxis The guideline on
Therapeutics Handbook Update July 2018
Posted: Friday, July 13, 2018
Category - Medicines Update
Latest Medicines Updates & News
MU Extra - QT prolongation
Posted: Friday, July 13, 2018
Category - Medicines Update
The Medicines Update Extra Bulletin on Drug induced QT prolongation has been updated. This consists of a
MUE 08: Drug induced QT prolongation
Posted: Friday, July 13, 2018
Category - Medicines Update Extra
MUE 08: Drug induced QT prolongation
** This bulletin supersedes MUE 02 **
- Prolongation of the QT interval can lead to a life threatening arrhythmia known as torsades de pointes.
- Over the last few years a number of warnings have highlighted the risk of QT prolongation with citalopram, domperidone, ondansetron, hydroxyzine and quinine.
- Extra vigilance is required by healthcare professionals to be alert to the risk of drug induced QT prolongation and drug interactions.
- Refer to flowchart and patient scenarios for further detail.
Guideline News June 2018
Posted: Wednesday, July 11, 2018
Category - Medicines Update
New Adult NHSGGC Guidelines now available on StaffNet
MHRA Updates Jun 18
Posted: Wednesday, July 11, 2018
Category - Medicines Update
Drug Safety Update (June 2018) includes: Dolutegravir (Tivicay ▼, ...
Formulary Update (June 2018)
Posted: Wednesday, June 20, 2018
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.
Valproate: NHSGGC Stakeholders Meeting
Posted: Friday, May 18, 2018
Category - Medicines Update
New drug safety advice from the MHRA regarding
Drug Safety Information: valproate medicines
Posted: Thursday, May 3, 2018
Category - Medicines Update
Important new drug safety information from the MHRA regarding
Edoxaban is the DOAC of choice in non-valvular atrial fibrillation
Posted: Thursday, May 3, 2018
Category - Medicines Update
The following is a joint quote from David Murdoch, Chair of the Heart MCN and Christine McAlpine, Chair of the Stroke MCN in NHSGGC. “The Heart MCN supported by the Stroke MCN have updated the atrial fibrillation (AF)&nb...
Formulary Update (April 2018)
Posted: Wednesday, May 2, 2018
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.